Clinical and Immunological Outcomes in Dogs with Osteosarcoma Treated with Intratumoral Interleukin-12 Microspheres
|Study End Date:||Ongoing|
|Enrollment Status:||CLOSED to new enrollment|
|Lead Researcher(s):||Dr. Stuart Helfand|
Dogs who undergo amputation and chemotherapy often have extended lives but 99% of these dogs develop metastatic disease. This study investigates a novel way to possibly delay the onset of metastatic disease. The Irish Wolfhound Foundation has pledged $3000 in financial support for this study. This study will involve all breeds and is sponsored by the Canine Health Foundation.
Dr. Stuart Helfand from the University of Wisconsin Veterinary Teaching Hospital is the principal investigator.
Individual content is copyrighted by its respective author(s) and the IWF. Please contact the IWF for reprint permission.